RU2012121242A - METHOD OF PHARMACOLOGICAL CORRECTION OF ISCHEMIA OF THE SKELETAL MUSCLE BY NICORANDIL - Google Patents
METHOD OF PHARMACOLOGICAL CORRECTION OF ISCHEMIA OF THE SKELETAL MUSCLE BY NICORANDIL Download PDFInfo
- Publication number
- RU2012121242A RU2012121242A RU2012121242/14A RU2012121242A RU2012121242A RU 2012121242 A RU2012121242 A RU 2012121242A RU 2012121242/14 A RU2012121242/14 A RU 2012121242/14A RU 2012121242 A RU2012121242 A RU 2012121242A RU 2012121242 A RU2012121242 A RU 2012121242A
- Authority
- RU
- Russia
- Prior art keywords
- nicorandil
- skeletal muscle
- ischemia
- experiment
- day
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Способ фармакологической коррекции ишемии скелетной мышцы никорандилом, отличающийся тем, что при моделировании ишемии скелетной мышцы, на вторые сутки эксперимента, лабораторному животному внутрижелудочно вводят никорандил в суточной дозе 1,3 мг/кг в 2 приема, на первые, четвертые и седьмые сутки эксперимента.A method for pharmacologically correcting skeletal muscle ischemia with nicorandil, characterized in that, when modeling skeletal muscle ischemia, on the second day of the experiment, Nicorandil is administered intragastrically to the laboratory animal in a daily dose of 1.3 mg / kg in 2 doses, on the first, fourth and seventh day of the experiment.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2012121242/14A RU2507597C2 (en) | 2012-05-23 | 2012-05-23 | Method for pharmacological correction of skeletal muscle ischemia with nicorandyl |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2012121242/14A RU2507597C2 (en) | 2012-05-23 | 2012-05-23 | Method for pharmacological correction of skeletal muscle ischemia with nicorandyl |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2012121242A true RU2012121242A (en) | 2013-11-27 |
RU2507597C2 RU2507597C2 (en) | 2014-02-20 |
Family
ID=49625026
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2012121242/14A RU2507597C2 (en) | 2012-05-23 | 2012-05-23 | Method for pharmacological correction of skeletal muscle ischemia with nicorandyl |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2507597C2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2559937C1 (en) * | 2014-08-12 | 2015-08-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Method for pharmacological stimulation of neoangiogenesis in treating acute experimental limb ischemia |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2735838C1 (en) * | 2020-03-21 | 2020-11-09 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный университет" | Method for pharmacological correction of experimental critical skeletal muscle ischemia with a combination of simvastatin and mononuclear fraction of autologous bone marrow |
RU2726077C1 (en) * | 2020-03-21 | 2020-07-08 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный университет" | Method for pharmacological correction of experimental critical skeletal muscle ischemia with a combination of simvastatin, udenafil and mononuclear fraction of autologous bone marrow |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2341517C2 (en) * | 2005-09-14 | 2008-12-20 | Некоммерческая организация Учреждение Институт проблем химической физики Российской академии наук (статус государственного учреждения (ИПХФ РАН) | Method of obtaining n-(2-nitroxyethyl)nicotinamide from ethylnicotinate |
US7589212B2 (en) * | 2006-06-27 | 2009-09-15 | Procter & Gamble Company | Human protein tyrosine phosphatase inhibitors and methods of use |
WO2008156513A2 (en) * | 2007-03-29 | 2008-12-24 | University Of Connecticut | Methods to protect skeletal muscle against injury |
RU2426174C1 (en) * | 2010-03-29 | 2011-08-10 | Государственное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" | Method of pharmacological correction of extremity ischemia including in l-name induced nitrogen oxide deficiency |
-
2012
- 2012-05-23 RU RU2012121242/14A patent/RU2507597C2/en not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2559937C1 (en) * | 2014-08-12 | 2015-08-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Method for pharmacological stimulation of neoangiogenesis in treating acute experimental limb ischemia |
Also Published As
Publication number | Publication date |
---|---|
RU2507597C2 (en) | 2014-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12015501993B1 (en) | Pyrazole-amide compound and medicinal uses therefor | |
EA201490228A1 (en) | NEW DERIVATIVES OF TRIFTOROMETHYLOROXIAZOLE AND THEIR APPLICATION FOR THE TREATMENT OF DISEASE | |
EA201690223A1 (en) | FACTOR INHIBITORS IN THE COMPLEMENT BASED ON PIPERIDININILINDOL DERIVATIVES AND THEIR APPLICATION | |
EA201690287A1 (en) | 1,4-DESIGNED ANALOGUES OF PYRIDAZIN QUINOLINE AND METHODS OF TREATING CONDITIONS ASSOCIATED WITH SMN-DEFICIENCY | |
CL2015002164A1 (en) | Combined formulation of two antiviral compounds. | |
EA201592250A1 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of diseases | |
EA201491671A1 (en) | Heterocyclic Compounds | |
EA201891804A1 (en) | TETRACYCLINE CONNECTIONS | |
BR112016007414A2 (en) | method of producing a monolayer tablet, and monolayer tablet | |
MY200278A (en) | Methods of improving exercise capacity in fontan patients using udenafil compositions | |
RU2012121242A (en) | METHOD OF PHARMACOLOGICAL CORRECTION OF ISCHEMIA OF THE SKELETAL MUSCLE BY NICORANDIL | |
EA201691299A1 (en) | APPLICATION OF LACHINIMODA TO SLOW DOWN THE PROGRESSION OF HANTINGTON'S DISEASE | |
RU2012104984A (en) | METHOD FOR PHARMACOLOGICAL CORRECTION OF SKELETAL ISCHEMIA ISCHEMIA SILDENAFIL, INCLUDING L-NAME-INDUCED NITROGEN OXIDE DEFICIENCY | |
RU2012112099A (en) | METHOD OF PHARMACOLOGICAL CORRECTION OF SKELETAL ISCHEMIA ISCHEMIA MINOXIDIL | |
RU2012152490A (en) | METHOD FOR PHARMACOLOGICAL CORRECTION OF ISCHEMIA OF THE SKELETAL MUSCLE WITH RESVERATROLOM | |
RU2010144193A (en) | METHOD FOR CORRECTION OF DISTURBANCES OF MICROCIRCULATION IN THE PLACENTA AT ADMA-LIKE MODEL OF HESTOSIS | |
EA201692090A1 (en) | POLYCYCLIC ACTIVATORS HERG | |
RU2016117845A (en) | CHEMICAL GASTRITIS MODELING METHOD | |
RU2013146757A (en) | METHOD FOR MODELING NSAID-HEPATOPATHY IN EXPERIMENT | |
RU2010111324A (en) | METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION WITH ADMA-SIMILAR PATHOLOGY MODEL IN PREGNANT ANIMALS | |
RU2013140842A (en) | METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY COMBINATION OF ROSUVASTATIN AND THIOIC ACID IN L-NAME-INDUCED NITROGEN OXIDE DEFICIENCY | |
RU2012108545A (en) | METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY AZITHROMYCIN IN AN ADMA-LIKE HESTOSIS MODEL IN EXPERIMENT | |
RU2012114543A (en) | METHOD FOR L-NAME CORRECTION OF INDUCED NITROGEN OXIDE DEFICIENCY BY TADALAFIL AND L-NORVALIN COMBINATION IN EXPERIMENT | |
RU2012124210A (en) | METHOD FOR PHARMACOLOGICAL STIMULATION OF SURGERY OF THE SKIN FLAP ON A FEEDING FOOT NICORANDIL | |
UA51089U (en) | Method for correcting nephropathy in setting of arterial hypertension in experiment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20140524 |